BiotechTube
Home/NuVision Biotherapies/Tim Gray
TG

Tim Gray

Chief Financial Officer

NuVision Biotherapies

Therapeutic Areas

OphthalmologyRegenerative Medicine

NuVision Biotherapies Pipeline

DrugIndicationPhase
OmnigenOcular surface wound healing (e.g., corneal defects, ulcers, dry eye disease)Commercial
OmniLenzSurgery-free ocular care (therapeutic contact lens)Commercial

Leadership Team at NuVision Biotherapies

RT
Roger Teasdale
Chairman
NW
Noel Waters
Chief Operating Officer
DA
Dr. Andrew Hopkinson
Founder and Chief Scientific Officer
View full NuVision Biotherapies profile